DANIEL KNOWLES: Open Payments
NPI 1972169373 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,107 in 48 payments from 19 companies in 2025. Trend: 2023 $1,864 · 2024 $1,468 · 2025 $1,107
Food & beverage: $1,107
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $146 |
| Boston Scientific Corporation | 2 | $144 |
| SCPHARMACEUTICALS INC. | 5 | $113 |
| PFIZER INC. | 5 | $104 |
| Abbott Laboratories | 1 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $78 |
| BridgeBio Pharma, Inc. | 3 | $64 |
| Philips North America LLC | 2 | $49 |
| Esperion Therapeutics, Inc. | 3 | $48 |
| Becton, Dickinson and Company | 1 | $42 |
Products named: LEQVIO, WATCHMAN FLX, FUROSCIX, CARDIOMEMS, JARDIANCE, VYNDAQEL, Attruby, NEXLETOL.
Industry payments across SC — which companies pay providers there.
